The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment

Clinical trial NCT07643896 · RECRUITING

Trial details

NCT number: NCT07643896
Sponsor: BillionToOne Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Pregnant Individuals Aneuploidy Down Syndrome (Trisomy 21)22q11.2 Deletion Syndrome Trisomy 13 Trisomy 18 Sex Chromosome Abnormalities

Start date: 2026-01-10
Primary completion: 2027-12-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.